Jazz Pharmaceuticals
JAZZ
HK$915.23
Share price
-0.66%
Change (1 day)
5.43%
Change (1 year)
Categories
Jazz Pharmaceuticals (JAZZ) - Total liabilities
Total liabilities on the balance sheet as of March 2025 : HK$57.76 Billion
According to Jazz Pharmaceuticals's latest financial reports the company's total liabilities are HK$57.76 Billion. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Jazz Pharmaceuticals - Total liabilities on balance sheet (from 2005 to 2025)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2024-12-31 | HK$61.47 B | 2.81% |
| 2023-12-31 | HK$59.79 B | -1.24% |
| 2022-12-31 | HK$60.54 B | -6.82% |
| 2021-12-31 | HK$64.98 B | 191.44% |
| 2020-12-31 | HK$22.29 B | 17.92% |
| 2019-12-31 | HK$18.90 B | -1.28% |
| 2018-12-31 | HK$19.15 B | 1.71% |
| 2017-12-31 | HK$18.83 B | -16.91% |
| 2016-12-31 | HK$22.66 B | 68.65% |
| 2015-12-31 | HK$13.43 B | -11.95% |
| 2014-12-31 | HK$15.26 B | 108.8% |
| 2013-12-31 | HK$7.30 B | 11.58% |
| 2012-12-31 | HK$6.55 B | 1287.67% |
| 2011-12-31 | HK$0.47 B | -42.32% |
| 2010-12-31 | HK$0.81 B | -41.43% |
| 2009-12-31 | HK$1.39 B | -14.04% |
| 2008-12-31 | HK$1.62 B | 36.67% |
| 2007-12-31 | HK$1.18 B | -60.87% |
| 2006-12-31 | HK$3.03 B | 38.53% |
| 2005-12-31 | HK$2.19 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Endo International
ENDPQ | HK$92.11 B | 59.45% | 🇮🇪 Ireland |
 AmerisourceBergen
ABC | HK$472.96 B | 718.71% | 🇺🇸 USA |
 Novartis NVS | HK$482.64 B | 735.47% | 🇨🇭 Switzerland |
 Teva Pharmaceutical Industries TEVA | HK$252.32 B | 336.78% | 🇮🇱 Israel |